Nov 13 (Reuters) – AstraZeneca has cut about 600 jobs from its respiratory and immunology commercial teams in the US as part of its cost savings initiative, Bloomberg News reported on Friday, citing people familiar with the matter.
Reuters could not immediately verify the report.
(Reporting by Unnamalai L in Bengaluru; Editing by Leroy Leo)
